Sept 16 (Reuters) – Perrigo Company Plc, the
generic drug manufacturer targeted by activist investor
Starboard Value LP, is exploring a sale of the royalties it
receives from sales of multiple…
The post Perrigo explores sale of royalties of drug Tysabri -sources appeared first on NASDAQ.